R&D Decisions

Sunk Cost in R&D: How to Reopen a Protected Decision

Published 2026-08-22 · Updated 2026-08-22

Answer in brief

Sunk Cost in R&D can shorten the search only by eliminating weak directions early. Start with whether continued investment reflects new evidence or accumulated commitment; compare mechanisms against forward-looking value, unresolved risks, alternative uses, switching cost, team incentives, and prior forecasts; and try to break the ranking with this challenge: restate the decision as if the program were offered today with no ownership history. A negative result is valuable when it prevents the wrong validation cycle.

Evidence status: Decision-method guide; not a completed investigation or final validation.

The decision this guide supports

whether continued investment reflects new evidence or accumulated commitment

Why the problem is difficult

The article-specific identification challenge is whether the question “whether continued investment reflects new evidence or accumulated commitment” can be resolved using forward-looking value, unresolved risks, alternative uses, switching cost, team incentives, and prior forecasts, rather than merely restated in new language.

A falsifier-first workflow

  • Define the decision precisely: whether continued investment reflects new evidence or accumulated commitment.
  • Build a source and data ledger around forward-looking value, unresolved risks, alternative uses, switching cost, team incentives, and prior forecasts.
  • Compare the inherited route with a mechanistically distinct alternative and a constraint-based null.
  • Actively search for the strongest counterevidence relevant to this decision, including boundary cases and prior failures.
  • Run the lowest-cost discriminating challenge: restate the decision as if the program were offered today with no ownership history.
  • Record pursue, reframe, or stop, the confidence level, the evidence ceiling, and who owns downstream validation.

Decision criteria

  • Decision impact: would the result materially change the choice about whether continued investment reflects new evidence or accumulated commitment?
  • Evidence fit: does the available evidence—forward-looking value, unresolved risks, alternative uses, switching cost, team incentives, and prior forecasts—directly address the decision rather than merely correlate with it?
  • Discrimination: does the preferred route predict an outcome a credible alternative does not?
  • Robustness: does the ranking survive the challenge “restate the decision as if the program were offered today with no ownership history”?
  • Validation boundary: is the conclusion no stronger than the available sources, data and computation?

Supporting evidence

forward-looking value, unresolved risks, alternative uses, switching cost, team incentives, and prior forecasts

Counterevidence

For this decision, a result from “restate the decision as if the program were offered today with no ownership history” that reverses or flattens the ranking must remain visible even when it is commercially inconvenient.

Computation

Here computation earns its place only if it changes the choice about whether continued investment reflects new evidence or accumulated commitment or exposes why the available evidence cannot resolve it.

Fastest falsifier

restate the decision as if the program were offered today with no ownership history

When to stop or reframe

A decision-specific stop trigger is failure of the challenge “restate the decision as if the program were offered today with no ownership history” without an independently supported alternative mechanism.

Evidence ceiling

A fresh-eye review can still miss tacit knowledge and transition costs.

Sources and starting points

Continue the decision journey

  1. An R&D Go/No-Go Framework With Real Stop Conditions
  2. R&D Portfolio Prioritization Under Scientific Uncertainty
  3. Build an Evidence Map for an R&D Decision
  4. Research Stop Conditions: Decide Before the Results Arrive

Explore the full topic hub · Editorial standard · Scientific Oracle consulting

Frequently asked questions

What decision does “Sunk Cost in R&D: How to Reopen a Protected Decision” help make?
It supports a bounded decision about whether continued investment reflects new evidence or accumulated commitment. The framework keeps alternatives, evidence, counterevidence, uncertainty, and the fastest falsification test visible.
What is the fastest useful test?
restate the decision as if the program were offered today with no ownership history
Can computation validate the final scientific claim?
No. A fresh-eye review can still miss tacit knowledge and transition costs. Computation can prioritize and eliminate directions; final validation remains with the appropriate domain methods and accountable specialists.
When should the project stop or reframe?
Stop or reframe when no plausible outcome changes the allocation decision, critical evidence is unavailable, the thesis depends on untestable assumptions, or a cheaper route dominates on information gained per unit of cost and time.